Xiamen Amoytop Valuation
| 688278 Stock | 73.51 0.41 0.56% |
At this time, the company appears to be undervalued. Xiamen Amoytop Biotech maintains a prevalent Real Value of USD78.29 per share. The last-minute price of the company is USD73.51. Our model calculates the value of Xiamen Amoytop Biotech from examining the company fundamentals such as Profit Margin of 0.29 %, return on asset of 0.22, and Current Valuation of 29.33 B as well as analyzing its technical indicators and probability of bankruptcy.
Price Book 13.2052 | Enterprise Value 29.3 B | Enterprise Value Ebitda 34.9479 | Price Sales 11.5226 | Trailing PE 40.3901 |
Undervalued
Today
Please note that Xiamen Amoytop's price fluctuation is very steady at this time. Calculation of the real value of Xiamen Amoytop Biotech is based on 3 months time horizon. Increasing Xiamen Amoytop's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Xiamen Amoytop is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Xiamen Stock. However, Xiamen Amoytop's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 73.51 | Real 78.29 | Hype 73.51 |
The real value of Xiamen Stock, also known as its intrinsic value, is the underlying worth of Xiamen Amoytop Biotech Company, which is reflected in its stock price. It is based on Xiamen Amoytop's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Xiamen Amoytop's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Xiamen Amoytop Biotech helps investors to forecast how Xiamen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Xiamen Amoytop more accurately as focusing exclusively on Xiamen Amoytop's fundamentals will not take into account other important factors: Xiamen Amoytop Cash |
|
Xiamen Amoytop Total Value Analysis
Xiamen Amoytop Biotech is presently forecasted to have takeover price of 29.33 B with market capitalization of 29.9 B, debt of 4.16 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Xiamen Amoytop fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
29.33 B | 29.9 B | 4.16 M |
Xiamen Amoytop Investor Information
About 67.0% of the company shares are owned by insiders or employees . The company last dividend was issued on the 23rd of May 2024. Based on the analysis of Xiamen Amoytop's profitability, liquidity, and operating efficiency, Xiamen Amoytop Biotech is performing exceptionally good at this time. It has a great odds to report excellent financial results in February.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 826.4 M | 787.1 M |
|
|
Xiamen Amoytop Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Xiamen Amoytop has an asset utilization ratio of 89.14 percent. This suggests that the Company is making USD0.89 for each dollar of assets. An increasing asset utilization means that Xiamen Amoytop Biotech is more efficient with each dollar of assets it utilizes for everyday operations.Xiamen Amoytop Ownership Allocation
Xiamen Amoytop Biotech retains a total of 406.8 Million outstanding shares. Xiamen Amoytop Biotech maintains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 67.08 (%) of Xiamen Amoytop Biotech outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.Xiamen Amoytop Profitability Analysis
The company reported the revenue of 2.1 B. Net Income was 554.35 M with profit before overhead, payroll, taxes, and interest of 1.53 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Xiamen Amoytop's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Xiamen Amoytop and how it compares across the competition.
About Xiamen Amoytop Valuation
The stock valuation mechanism determines Xiamen Amoytop's current worth on a weekly basis. Our valuation model uses a comparative analysis of Xiamen Amoytop. We calculate exposure to Xiamen Amoytop's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Xiamen Amoytop's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2.3 B | 2.4 B |
Xiamen Amoytop Quarterly Retained Earnings |
|
Complementary Tools for Xiamen Stock analysis
When running Xiamen Amoytop's price analysis, check to measure Xiamen Amoytop's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xiamen Amoytop is operating at the current time. Most of Xiamen Amoytop's value examination focuses on studying past and present price action to predict the probability of Xiamen Amoytop's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xiamen Amoytop's price. Additionally, you may evaluate how the addition of Xiamen Amoytop to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |